| Literature DB >> 36111310 |
Dan Shan1, Chang Liu2, Shaoyang Li3, Yuandian Zheng4.
Abstract
Background: Policies dealing with the Coronavirus Disease 2019 (COVID-19) pandemic vary across the globe, the different governmental responses then affect the public perception of COVID-19. Many unofficial Chinese media outlets frequently spread misinformation about COVID-19 and exaggerated reports of rare sequelae of Omicron for monetization and attention seeking, leading to panics in the Chinese public. In comparison the attitudes toward Omicron in other countries around the world, especially in North America and Western Europe have shifted to a more relaxed stance. Objective: This article primarily aims to investigate the association between Chinese people's attitudes toward the potential after-effects of Omicron and their anxiety status, as compared to these of people living in North America or Western Europe.Entities:
Keywords: COVID-19; Omicron; anxiety; pandemic; sequelae
Year: 2022 PMID: 36111310 PMCID: PMC9468740 DOI: 10.3389/fpsyt.2022.977361
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
Sample description.
| China (Shanghai) | China (non-Shanghai) | North America or Europe | |
|
| |||
|
| |||
| Male | 278 (55.6) | 291 (58.2) | 243 (48.6) |
| Female | 222 (44.4) | 209 (41.8) | 257 (51.4) |
|
| |||
| 1 dose | 13 (2.6) | 10 (2) | 68 (13.6) |
| 2 doses | 28 (5.6) | 110 (22) | 105 (21.0) |
| 3 doses | 459 (91.8) | 380 (76) | 327 (65.4) |
|
| |||
| Yes | 14 (2.8) | 4 (0.8) | 393 (78.6) |
| No | 486 (97.2) | 496 (99.2) | 107 (21.4) |
|
| |||
| Support zero-tolerance approach (because of fearing sequelae of Omicron) | 212 (42.4) | 335 (67.0) | 39 (7.8) |
| Support zero-tolerance approach (because of misgiving medical resource crowding) | 93 (18.6) | 79 (15.8) | 20 (4) |
| Support co-existence with virus as much as possible | 195 (39) | 86 (17.2) | 441 (88.2) |
|
| |||
| No | 247 (49.4) | 259 (51.8) | 483 (96.6) |
| Yes | 253 (50.6) | 241 (48.2) | 17 (3.4) |
|
| |||
| No sequelae | 5 (1.0) | 11 (2.2) | 283 (56.6) |
| Mild sequelae | 54 (10.8) | 229 (45.8) | 106 (21.2) |
| Moderate sequelae | 185 (37.0) | 146 (29.2) | 67 (13.4) |
| Severe sequelae | 256 (51.2) | 114 (22.8) | 44 (8.8) |
General anxiety disorder 7-item (GAD-7) scores of participants (N = 1,500).
| Variables | GAD-7 scores | ||||||||
| Means ( | [95%CI] |
| |||||||
| CN SH | CN Non-SH | NA and WE | CN SH | CN Non-SH | NA and WE | CN SH | CN Non-SH | NA and WE | |
| Gender | 0.578 | 0.731 | 0.664 | ||||||
| Male | 8.74 (3.97) | 5.23 (2.34) | 3.77 (1.80) | [8.27, 9.21] | [4.96, 5.50] | [3.54, 4.00] | |||
| Female | 9.11 (3.75) | 6.03 (2.08) | 4.11 (2.66) | [8.62, 9.60] | [5.75, 6.31] | [3.78, 4.44] | |||
| Vaccination status | 0.344 | 0.544 | 0.650 | ||||||
| 1 Dose | 8.69 (3.97) | 7.00 (3.33) | 4.21 (2.59) | [6.53, 10.85] | [4.93, 9.07] | [3.59, 4.83] | |||
| 2 Doses | 10.07 (4.81) | 5.70 (3.71) | 3.92 (2.57) | [8.29, 11.85] | [5.01, 6.39] | [3.43, 4.41] | |||
| 3 Doses | 8.98 (3.87) | 5.76 (3.56) | 3.89 (2.52) | [8.63, 9.33] | [5.40, 6.12] | [3.62, 4.16] | |||
| Infection status | 0.000 | 0.837 | 0.067 | ||||||
| Yes | 4.06 (2.65) | 10.50 (4.04) | 3.89 (2.48) | [2.67, 5.45] | [6.54, 14.46] | [3.64, 4.14] | |||
| No | 7.07 (4.11) | 5.73 (3.56) | 4.15 (2.74) | [6.70, 7.44] | [5.42, 6.04] | [3.63, 4.67] | |||
| VOC | 0.936 | 0.092 | 0.099 | ||||||
| SZAFS | 9.17 (3.86) | 5.63 (3.54) | 4.73 (3.07) | [8.62, 9.72] | [5.25, 6.01] | [3.77, 5.69] | |||
| SZAMM | 8.93 (3.93) | 7.16 (4.17) | 4.64 (2.29) | [8.13, 9.73] | [6.24, 8.08] | [3.64, 5.64] | |||
| SCV | 9.35 (3.31) | 6.05 (3.17) | 4.50 (2.87) | [8.89, 9.81] | [5.38, 6.72] | [4.23, 4.77] | |||
| PFTF | 0.823 | 0.526 | 0.284 | ||||||
| Yes | 9.13 (3.86) | 5.83 (3.54) | 3.29 (2.14) | [8.65, 9.61] | [5.38, 6.28] | [2.27, 4.31] | |||
| No | 8.94 (4.00) | 5.71 (3.64) | 3.96 (2.55) | [8.44, 9.44] | [5.27, 6.15] | [3.73, 4.19] | |||
| SATSO | 0.000 | 0.000 | 0.060 | ||||||
| No sequelae | 6.80 (5.36) | 3.64 (3.91) | 3.95 (2.50) | [2.11, 11.49] | [1.33, 5.95] | [3.66, 4.24] | |||
| Mild sequelae | 7.04 (3.93) | 4.64 (3.36) | 3.45 (2.69) | [5.99, 8.09] | [4.20, 5.08] | [2.94, 3.96] | |||
| Moderate sequelae | 7.17 (2.73) | 5.31 (2.34) | 4.42 (2.23) | [6.78, 7.56] | [4.93, 5.69] | [3.89, 4.95] | |||
| Severe sequelae | 10.85 (3.79) | 8.82 (3.61) | 4.34 (2.68) | [10.39, 11.31] | [8.16, 9.48] | [3.55, 5.13] | |||
CN, China, SH, Shanghai, NA, North America; WE, Western Europe; VOC, View of coexistence with COVID-19; SZAFS, Support zero-tolerance approach (because of fearing sequelae of Omicron); SZAMM, Support zero-tolerance approach (because of misgiving medical resource crowding); SCV, Support co-existence with virus as much as possible; PFTF, Psychological fear toward friends infected with COVID-19; SATSO, Subjective attitude toward the sequelae of Omicron.
FIGURE 1Mean of GAD-7 scores by area.
Correlation between SATSO and GAD-7 scores among different areas.
| Kendall’s tau-b | SATSO in China (Shanghai) ( | SATSO in China outside Shanghai ( | SATSO in North America and Western Europe ( | |
| GAD-7 scores | Correlation coefficient | 0.44 | 0.37 | −0.01 |
| Sig. (2-tailed) | 0.00 | 0.00 | 0.70 | |
N = 1,500. **Representing the correlation is significant at the 0.01 level (p < 0.01).
SATSO, Subjective attitude toward the sequelae of Omicron.